Inhibition of cyclosporin A/FK506 resistant, lymphokine-induced T-cell activation by phenothiazine derivatives.
Schleuning, M
Inhibition of cyclosporin A/FK506 resistant, lymphokine-induced T-cell activation by phenothiazine derivatives. [electronic resource] - Naunyn-Schmiedeberg's archives of pharmacology Jul 1994 - 100-3 p. digital
Publication Type: Journal Article
0028-1298
10.1007/BF00180018 doi
Cell Division
Cell Line
Cells, Cultured
Chlorpromazine--pharmacology
Cyclosporine--pharmacology
Fluphenazine--pharmacology
Humans
Interleukin-2--biosynthesis
Lymphocyte Activation--drug effects
Receptors, Interleukin--metabolism
Receptors, Interleukin-2--metabolism
Signal Transduction--drug effects
T-Lymphocytes--drug effects
Tacrolimus--pharmacology
Inhibition of cyclosporin A/FK506 resistant, lymphokine-induced T-cell activation by phenothiazine derivatives. [electronic resource] - Naunyn-Schmiedeberg's archives of pharmacology Jul 1994 - 100-3 p. digital
Publication Type: Journal Article
0028-1298
10.1007/BF00180018 doi
Cell Division
Cell Line
Cells, Cultured
Chlorpromazine--pharmacology
Cyclosporine--pharmacology
Fluphenazine--pharmacology
Humans
Interleukin-2--biosynthesis
Lymphocyte Activation--drug effects
Receptors, Interleukin--metabolism
Receptors, Interleukin-2--metabolism
Signal Transduction--drug effects
T-Lymphocytes--drug effects
Tacrolimus--pharmacology